333 results on '"Fornier, Monica"'
Search Results
2. Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2− breast cancer
3. Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?
4. How Effective is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery?
5. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
6. Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
7. Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score
8. A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer
9. Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients
10. Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
11. Abstract CT144: Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- breast cancer
12. Data from Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer
13. Supplementary Data from Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer
14. Supplementary Appendix 1 from Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer
15. Supplementary Tables 1 - 3 from Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer
16. Supplementary Data from A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer
17. Abstract P5-08-10: Safety and Tolerability of Paxman Scalp Cooling at Lower Temperatures to Improve Efficacy with Anthracycline Chemotherapy
18. Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study
19. Development of Inhibitors of HER2 With Taxanes
20. Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases
21. Oral minoxidil for the treatment of late alopecia in cancer survivors.
22. Anthracyclines in the adjuvant treatment of breast cancer: state of the art
23. Optimizing the use of anthracyclines in older patients with breast cancer
24. Approved Agents for Metastatic Breast Cancer
25. Algorithms for the Treatment of Patients With Metastatic Breast Cancer and Prior Exposure to Taxanes and Anthracyclines
26. Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
27. Ixabepilone Plus Capecitabine for Breast Cancer Patients With an Early Metastatic Relapse After Adjuvant Chemotherapy: Two Clinical Trials
28. Does Preoperative MRI Accurately Stratify Early-stage HER2+ Breast Cancer Patients to Upfront Surgery vs NAC?
29. Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials
30. Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
31. Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity
32. Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer
33. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
34. Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials
35. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective
36. Ixabepilone, First in a New Class of Antineoplastic Agents: The Natural Epothilones and Their Analogues
37. Adjuvant chemotherapy for primary breast cancer
38. A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer
39. Vertebral Fractures After Denosumab Discontinuation in Breast Cancer Survivors: A Single Institution Experience
40. Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer
41. The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment
42. Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy
43. Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer
44. Vertebral fractures after denosumab discontinuation in breast cancer survivors---a single institution experience
45. A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases
46. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
47. HISTOMORPHOLOGIC ANALYSIS OF BISPHOSPHONATE-ELATED OSTEONECROSIS OF THE JAW
48. Novel anti-tubulin cytotoxic agents for breast cancer
49. GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
50. Challenging patient populations in breast cancer: Taxane resistance and triple-negative receptor subtype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.